Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Clover Health Jumps as CMS Approves Firm’s Expansion Plans for 2022

Published 09/22/2021, 11:46 AM
Updated 09/22/2021, 11:47 AM
© Reuters.

© Reuters.

By Dhirendra Tripathi

Investing.com – Clover Health stock (NASDAQ:CLOV) gained more than 2% Wednesday as the Centers for Medicare and Medicaid Services approved the company’s service area expansion to operate in 101 new counties.

Effective January 1, the approval brings Clover’s total coverage area for its Medicare advantage plans to 209 counties across nine states.

The new counties are in states of Georgia, New Jersey, South Carolina, Texas, and Alabama – a new territory for the company.

Individuals eligible for Medicare in any of the 209 counties can sign up for Clover’s plans during the annual election period, which runs from October 15 to December 7, the company said.

The company last month reported a doubling of revenue and memberships in the second quarter.

Clover is on a $1.6 billion annual revenue run rate based on the second quarter results, Clover Health CFO Joe Wagner said in an August 11 note.

Second-quarter revenue grew 140% to $412.5 million. But the company made a loss as against a profit last time because of a higher salary bill and administrative expenses.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.